Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study-Reference-Cited by-同舟云学术

Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study

Published:2022-10-26 Issue:1 Volume:128 Page:21-29
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Rodriguez-Vida Alejo,Maroto Pablo,Font Albert,Martin Cristina,Mellado Begoña,Corbera Alex,Orrillo Mayra,Reig Oscar,Querol Rosa,Rios-Hoyo Alejandro,Cano Laia,Alonso Judith,Martinez Gemma,Galtes Susana,Taus Alvaro,Martinez-Garcia Maria,Juanpere Nuria,Juan Oscar,Bellmunt Joaquim^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-022-01991-4.pdf

Reference47 articles.

1. Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer. 2010;46:3040–52.

2. Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, et al. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. 2015;373:737–46.

3. Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, et al. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. N Engl J Med. 2017;377:352–60.

4. Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, et al. Enzalutamide with standard first-line therapy in metastatic prostate cancer. N Engl J Med. 2019;381:121–31.

5. Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, et al. Apalutamide for metastatic, castration-sensitive prostate cancer. N Engl J Med. 2019;381:13–24.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectives;Cancer Treatment Reviews;2024-11

2. Advances in and prospects of immunotherapy for prostate cancer;Cancer Letters;2024-10

3. Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers;Nature Reviews Urology;2024-04-16

4. Therapeutic cancer vaccines: advancements, challenges, and prospects;Signal Transduction and Targeted Therapy;2023-12-13